Effect of Ethanol Extract of Cinnamon Bark (Cinnamomum burmanii) on the Lipid Profile and Malondialdehyde of Dyslipidemic Rats
Keywords:cinnamon, dyslipidemia, malondialdehyde, lipid profile
Dyslipidemia is a risk factor for atherosclerosis. Dyslipidemia conditions and malondialdehyde (MDAs) increased can cause oxidative stress. Cinnamon contains antioxidant compounds that have a hypolipidemic effect. This study aimed to determine the effect of cinnamon bark ethanol extract on triglycerides, total cholesterol, LDL, HDL, and MDA in dyslipidemic rats. In this study, rats were divided into five groups, a negative control group: which received standard feed, a positive control group: which received a high-fat diet and PTU, the groups that received a high-fat diet, PTU, cinnamon bark ethanol extract (EECB) 125 mg/Kg BW, 250 mg/Kg BW, 500 mg/Kg BW. The results of the analysis showed a decrease in triglyceride levels in all groups given EECB (p <0.05). Total and LDL cholesterol levels decreased in the 125 mg/Kg BW EECB group, and malondialdehyde decreased in the 500 mg/Kg BW EECB group (p <0.05). HDL levels did not increase. The ethanol extract of cinnamon bark was able to improve lipid profiles because it contains cinnamaldehyde and quercetin that can inhibit HMG CoA reductase activity, as well as flavonoids, tannins, and cinnamate which are able to reduce triglyceride and MDA levels.
Keywords: cinnamon, dyslipidemia, malondialdehyde, lipid profile.
Berman AN, Blankstein R. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options. Curr Cardiol Rep. 2019;21(9):1–10.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Vol. 140, Circulation. 2019. 563–595 p.
Kopin L, Lowenstein C. In the Clinic® dyslipidemia. Ann Intern Med. 2017;167(11):ITC81–95.
Burtenshaw D, Kitching M, Redmond EM, Megson IL, Cahill PA. Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease. Front Cardiovasc Med. 2019;6(August):1–18.
Tada H, Nohara A, Kawashiri MA. Serum triglycerides and atherosclerotic cardiovascular disease: Insights from clinical and genetic studies. Nutrients. 2018;10(11).
Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evidence-based Complement Altern Med. 2014;2014.
Susilowati R, Setiawan AM. Cinnamomum burmannii (Nees & T. Nees) Blume and Eleutherine palmifolia (L.) Merr. extract combination ameliorate lipid profile and heart oxidative stress in hyperlipidemic mice. Vet World. 2020;13(7):1404–9.
Liang Y, Li Y, Sun A, Liu X. Chemical compound identification and antibacterial activity evaluation of cinnamon extracts obtained by subcritical n-butane and ethanol extraction. Food Sci Nutr. 2019;7(6):2186–93.
Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: A review based on its mechanisms. Iran J Basic Med Sci. 2016;19(12):1258–70.
Lopes BP, Gaique TG, Souza LL, Paula GSM, Kluck GEG, Atella GC, et al. Cinnamon extract improves the body composition and attenuates lipogenic processes in the liver and adipose tissue of rats. Food Funct. 2015;6(10):3257–65.
Tuzcu Z, Orhan C, Sahin N, Juturu V, Sahin K. Cinnamon Polyphenol Extract Inhibits Hyperlipidemia and Inflammation by Modulation of Transcription Factors in High-Fat Diet-Fed Rats. Oxid Med Cell Longev. 2017;2017.
Ervina M, Nawu YE, Esar SY. Comparison of in vitro antioxidant activity of infusion, extract and fractions of Indonesian Cinnamon (Cinnamomum burmannii) bark. Int Food Res J. 2016;23(3):1346–50.
Mohammed H, Abdel Fattah D. Hypolipidemic and Hypoglycemic Effect of Cinnamon Extract in High Fat Diet Fed Rats. Zagazig Vet J. 2018;46(2):160–7.
Li J, Liu T, Wang L, Guo X, Xu T, Wu L, et al. Antihyperglycemic and antihyperlipidemic action of cinnamaldehyde in C57blks/j Db/db mice. J Tradit Chinese Med. 2012;32(3):446–52.
Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014.
Khoubnasabjafari M, Ansarin K, Jouyban A. Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders. BioImpacts [Internet]. 2015;5(3):123–7. Available from: http://dx.doi.org/10.15171/bi.2015.20
How to Cite
Copyright (c) 2023 Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher
The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).